Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 3,240,234 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 3,240,234 shares of Tempus AI stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the sale, the chief executive officer now owns 4,895,589 shares of the company’s stock, valued at approximately $287,615,853.75. This represents a 39.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Tempus AI Price Performance

NASDAQ:TEM opened at $55.30 on Friday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The stock has a 50-day simple moving average of $52.29 and a 200 day simple moving average of $52.27.

Analyst Ratings Changes

Several brokerages have commented on TEM. TD Cowen reiterated a “buy” rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. William Blair reaffirmed a “market perform” rating on shares of Tempus AI in a research note on Tuesday. Wolfe Research assumed coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective for the company. Bank of America increased their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and an average price target of $60.55.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. International Assets Investment Management LLC grew its holdings in shares of Tempus AI by 141,400.0% in the 3rd quarter. International Assets Investment Management LLC now owns 70,750 shares of the company’s stock valued at $4,004,000 after acquiring an additional 70,700 shares in the last quarter. Janney Capital Management LLC acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $385,000. Vestor Capital LLC bought a new stake in shares of Tempus AI during the 3rd quarter worth approximately $153,000. ARK Investment Management LLC boosted its holdings in shares of Tempus AI by 355.0% in the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after buying an additional 1,855,459 shares during the last quarter. Finally, Sigma Planning Corp acquired a new stake in shares of Tempus AI in the 3rd quarter valued at approximately $1,323,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.